Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
about
Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattlePatterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement.Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategiesShiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7.Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs.Probiotics: properties, examples, and specific applications.Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.Shiga toxin 1 causes direct renal injury in rats.Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models.A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection.Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.
P2860
Q33280033-81574D24-14CE-439D-917F-726EF15A1E46Q33363266-F6968DD9-D9BF-4675-84C9-9F86E2BB0EDDQ33364280-3214531C-F412-44A8-8DAC-299906C6D23AQ33376766-9E4D2676-205B-4F68-B1B8-C0E5E94572DBQ33397517-7C7BBF29-565A-491D-9404-C6F43E9F16EEQ33402959-AD21B81A-7783-4227-87CF-80080E16B13AQ33404640-2C1E50B5-8884-4377-89BD-E3B43E3BBA26Q33414177-60252DF2-74D4-40CB-8969-EFA7A2B67838Q33730844-6969FE37-3607-4369-8F7E-E73B0E69F5A1Q36375207-95BBDB04-4C9E-4BCF-89D3-9DF09450F291Q36629073-EBEF4866-8515-4EDD-8829-7B1DE8A17116Q37582841-9A567191-738E-40A6-AA6A-63B2D7946AC9Q37672981-4CFDC8FF-F9A6-4521-BDA3-48BA9598D030Q39392213-165CF8E7-A29E-48F0-9EB7-1B5600088D94Q40312938-D8B58A53-78BE-479F-BAE9-3F0616F7C8A3Q40738737-7A432B9A-315F-4491-BC57-D56672384F6DQ55516340-DF83914F-3354-4586-BD7D-70F90482329C
P2860
Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gnotobiotic piglets develop th ...... ohemorrhagic Escherichia coli.
@ast
Gnotobiotic piglets develop th ...... ohemorrhagic Escherichia coli.
@en
type
label
Gnotobiotic piglets develop th ...... ohemorrhagic Escherichia coli.
@ast
Gnotobiotic piglets develop th ...... ohemorrhagic Escherichia coli.
@en
prefLabel
Gnotobiotic piglets develop th ...... ohemorrhagic Escherichia coli.
@ast
Gnotobiotic piglets develop th ...... ohemorrhagic Escherichia coli.
@en
P2093
P1476
Gnotobiotic piglets develop th ...... ohemorrhagic Escherichia coli.
@en
P2093
Andreas Matussek
Florian Gunzer
Hans-Heinrich Kreipe
Hermann-Josef Gröne
Isabel Hennig-Pauka
Karl-Heinz Waldmann
Michael Mengel
Roger Sandhoff
P304
P356
10.1309/UMW9-D06Q-M94Q-JGH2
P407
P577
2002-09-01T00:00:00Z